CD8A and neoplasm: It is characterized by a gradual loss of effector functions and an inability to effectively respond to antigens, leading to compromised immune surveillance and host defense.[48] In this study, we demonstrated ApoVs treatment inducing apoptosis of CD8+ T cells, suggesting that timely clearance of ApoVs could be beneficial for CD8+ T cells in anti‐viral and anti‐tumor therapy.